Illumina Hits Affymetrix Over New Gene Tech Patent

Law360, New York (November 4, 2009, 1:25 PM EST) -- Illumina Inc. has hit Affymetrix Inc. with a lawsuit claiming the rival genetics research company’s GeneChip products infringe a recently issued patent covering gene-sequencing technology.

San Diego-based Illumina claims in its lawsuit, filed Tuesday in the U.S. District Court for the Western District of Wisconsin, that Affymetrix is infringing a patent that was approved by the U.S. Patent and Trademark office moments before the lawsuit was filed.

The lawsuit involves U.S. Patent 7,612,020, titled “Composite arrays utilizing microspheres with a hybridization chamber,” which was issued to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.